“…43 studies showed current landscape and applied scenario of AI used in cancer survivorship domain. Most of the studies were conducted in Europe ( n = 16) 10 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , Asia ( n = 12) 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , USA ( n = 12) 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 followed by Middle East ( n = 2) 53 , 54 , and UK ( n = 1) 55 Supplement A presents an overview of these studies’ characteristics. Based on the various clinical application and potential functions, the studies can be divided into following categories, they are 1.…”